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Background: Dronedarone (D), a new multichannel blocker for atrial fibrillation/flutter (AF/AFL), may be indicated for pts on prior amiodarone (A). 
Given the electrophysiological profile and long half-life of A, we evaluated the effect of starting D after A discontinuation.
Methods: In EURIDIS and ADONIS studies, 828 and 409 AF/AFL pts were randomized after conversion to SR to D (400 mg bid) or placebo (Pl) for 1 
yr. A subgroup of 98 D and 56 Pl pts (63.5 y, 35.7% women [W]) were switched from A to D within 48 h.
Results: D decreased AF/AFL recurrence compared to Pl (HR=0.64 [95% CI 0.44-0.95], P=0.022) in this subgroup. Rates of adverse events (AEs), 
specifically bradyarrhythmia, in this subgroup were compared to 334 Pl and 680 D pts (62.8 y; 29.7% W) with no previous A use and a smaller 
group of 17 and 35 pts (65.5 y; 30.8% W) switched >48 h (Table). There were slightly more bradyarrhythmic events leading to drug discontinuation 
and numerically more QTc-prolongations in switch pts, as expected from the pharmacodynamic profile of the drugs. Rate of serious AEs was low and 
similar across groups with no episodes of torsades de pointes.
Conclusions: This post hoc analysis of a small patient cohort switched rapidly from A to D resulted in good tolerability; further study is warranted.
Adverse events following switch from amiodarone to dronedarone
Events
A switch
≤ 48 H
A switch
> 48H
No previous A
Pl D Pl D Pl D
n=56 n=98 n=17 n=35 n=334 n=680
Deaths (n) 1 1 1 2 2 5
Rate of non fatal events (%)
Serious AEs
- bradyarrhythmia
14.3
0
15.3
1
11.8
0
17.1
0
16.2
0.9
13.7
1.3
AEs with drug discontinuation
- bradyarrhythmia
3.6
0
8.2
3.1
11.8
0
20.0
0
6.3
0
9.1
0.7
PR-interval ≥ 200 msec and increase ≥ 20 msec vs 
baseline
14.5 25.8 12.5 22.9 12.8 28.0
QTc-Fridericia ≥ 500 msec 3.6 7.9 6.7 14.3 0.3 4.4
